PLATFORM at 90 days: Evaluating the clinical utility of FFRCT

Authors

  • Ahmed Kharabish Aswan Heart Center, Aswan, Egypt
  • Ahmed ElGuindy Aswan Heart Center, Aswan, Egypt

DOI:

https://doi.org/10.21542/gcsp.2016.22

Abstract

The advancement that took place in assessing fractional flow reserve (FFR) using various competing modalities led to numerous research trials to evaluate the clinical impact of each. Among those trials is the recently published PLATFORM study. The data was designed to compare two clinical scenarios; a combination of computed fluid dynamics with computed tomographic angiography (CTA-guided strategy) in non-obstructive coronary artery disease (CAD) on one arm, compared to the standard practice representing the other clinical arm. The study’s results were evaluated for further evidence and clinical insights. 

Downloads

Published

2016-12-07

Issue

Vol. 2016 No. 3 (2016)

Section

Lessons from the trials

License

This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.